116 related articles for article (PubMed ID: 37669059)
1. Topical Administration of Bevacizumab to Facilitate the Functional Filtering Bleb After Trabeculectomy in the Rabbit.
Jiang C; Yin X; Chang J; Liu G; Lu P
J Ocul Pharmacol Ther; 2023 Dec; 39(10):716-724. PubMed ID: 37669059
[No Abstract] [Full Text] [Related]
2. Management of experimental trabeculectomy filtering blebs via crosslinking of the scleral flap inhibited vascularization.
Ge LY; Wu TH; Liu YQ; Jiang C; Yin X
Graefes Arch Clin Exp Ophthalmol; 2024 May; 262(5):1507-1517. PubMed ID: 37943331
[TBL] [Abstract][Full Text] [Related]
3. Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy.
Shi H; Wang H; Fu S; Xu K; Zhang X; Xiao Y; Ye W
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1478-1486. PubMed ID: 28273314
[TBL] [Abstract][Full Text] [Related]
4. Relationship between filtering bleb vascularization and surgical outcomes after trabeculectomy: an optical coherence tomography angiography study.
Yin X; Cai Q; Song R; He X; Lu P
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2399-2405. PubMed ID: 30209568
[TBL] [Abstract][Full Text] [Related]
5. The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits.
Yüksel R; Yüksel N; Yazır Y; Öztürk A; Furat Rençber S; Demirci Küçük K
Exp Eye Res; 2023 Apr; 229():109431. PubMed ID: 36870440
[TBL] [Abstract][Full Text] [Related]
6. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy.
Rodríguez-Agirretxe I; Vega SC; Rezola R; Vecino E; Mendicute J; Suarez-Cortes T; Acera A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5227-35. PubMed ID: 23800769
[TBL] [Abstract][Full Text] [Related]
7. Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor.
Sapitro J; Dunmire JJ; Scott SE; Sutariya V; Geldenhuys WJ; Hewit M; Yue BY; Nakamura H
Mol Vis; 2010 Sep; 16():1880-92. PubMed ID: 21031133
[TBL] [Abstract][Full Text] [Related]
8. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit.
Memarzadeh F; Varma R; Lin LT; Parikh JG; Dustin L; Alcaraz A; Eliott D
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3233-7. PubMed ID: 19182254
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Cheng JW; Cheng SW; Wei RL; Lu GC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009782. PubMed ID: 26769010
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery.
Zhang F; Liu K; Cao M; Qu J; Zhou D; Pan Z; Duan X; Zhou Y
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2743-2752. PubMed ID: 31247081
[TBL] [Abstract][Full Text] [Related]
11. Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy.
Igarashi N; Honjo M; Aihara M
Exp Eye Res; 2021 Feb; 203():108421. PubMed ID: 33359326
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408
[TBL] [Abstract][Full Text] [Related]
13. Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery.
Yan ZC; Bai YJ; Tian Z; Hu HY; You XH; Lin JX; Liu SR; Zhuo YH; Luo RJ
Mol Vis; 2011; 17():2495-506. PubMed ID: 21976960
[TBL] [Abstract][Full Text] [Related]
14. The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
Elgin U; Sen E; Ozdemir K; Ozdal P; Berker N
Int Ophthalmol; 2020 Apr; 40(4):795-802. PubMed ID: 31792855
[TBL] [Abstract][Full Text] [Related]
15. The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report.
Popescu V; Leasu C; Stana D; Alexandrescu C; Dumitrescu A
J Med Life; 2015; 8(1):103-5. PubMed ID: 25914750
[TBL] [Abstract][Full Text] [Related]
16. Forkhead domain inhibitory-6 attenuates subconjunctival fibrosis in rabbit model with trabeculectomy.
Lan C; Tan J; Tang L; Liu G; Huang L; Luo X; Zhou L; Zhu Y; Liu X; Fan N
Exp Eye Res; 2021 Sep; 210():108725. PubMed ID: 34375589
[TBL] [Abstract][Full Text] [Related]
17. The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model.
Ozgonul C; Mumcuoglu T; Gunal A
Curr Eye Res; 2014 May; 39(5):451-9. PubMed ID: 24215335
[TBL] [Abstract][Full Text] [Related]
18. Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs.
Tai TY; Moster MR; Pro MJ; Myers JS; Katz LJ
J Glaucoma; 2015; 24(4):311-5. PubMed ID: 25826644
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the Filtering Bleb and the Agreement between Glaucoma Specialist and Anterior Segment-Optical Coherence Tomography Assessment.
Zantut F; Gracitelli CPB; Souza PH; Teixeira SH; Paranhos A
Ophthalmic Res; 2021; 64(3):405-410. PubMed ID: 32942276
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Everolimus on Scar Formation in Glaucoma Filtering Surgery in a Rabbit Model.
Cinik R; Yüksel N; Pirhan D; Aslan MŞ; Subaşı C; Karaöz E
Curr Eye Res; 2016 Nov; 41(11):1438-1446. PubMed ID: 27116538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
